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TO THE EDITOR
Revertant mosaicism (RM) is a genetic
phenomenon that results in the sponta-
neous partial or complete correction of
an affected phenotype (Jonkman et al.,
1997). In the skin, RM has been
reported in various subtypes of epider-
molysis bullosa and ichthyosis with
confetti (for review, see Lai-Cheong
et al., 2011). The mechanisms under-
lying RM include back mutation, sec-
ond-site mutation, intragenic crossover,
and gene conversion (Jonkman et al.,
2003), and indeed several different
corrective processes can occur in the
same patient (Jonkman and Pasmooij,
2009). Here, we investigate a case of
RM in Kindler syndrome (KS; OMIM
173650), an autosomal recessive
disorder characterized by skin
fragility, atrophy, and photosensitivity
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Figure 1. Clinical features and molecular analysis of revertant skin. (a) In 2005, a small light brown patch measuring B0.5 cm in diameter was noted on
the dorsal aspect of the right hand (white arrow). (b) In 2008, a clinically healthy patch of skin measuring approximately 2.8 1.2 cm was present on the
dorsal aspect of the right hand. Marked skin atrophy surrounding the revertant patch was present. (c) In 2010, the patch was noted to have grown larger,
measuring approximately 3 1.5 cm. The reverted skin is delineated by the dashed lines. (d) Immunofluorescence microscopy labeling showed localization
of kindlin-1 in the basal keratinocyte layer of normal human skin. In the non-reverted skin, there was reduced kindlin-1 labeling, which differed from the
reverted skin in which kindlin-1 staining was bright (bar¼ 50 mm). (e) Sequence analysis showed a run of seven cytosines present in exon 5, labeled 1–7, in
normal control skin. In both reverted and non-reverted skin, there was an extra cytosine in the genomic DNA at nucleotide position, c.676, resulting in a
homozygous frameshift mutation denoted c.676dupC (red arrow). (f) In normal skin complementary DNA (cDNA), a run of seven cytosines was noted in
exon 5 of FERMT1. In the non-revertant skin cDNA, eight cytosines were present, correlating with the genomic DNA sequence analysis. In revertant
skin cDNA, wild-type sequence was present.
Abbreviations: cDNA, complementary DNA; KS, Kindler syndrome; RM, revertant mosaicism
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(Lai-Cheong et al., 2009). KS results
from pathogenic mutations in the
FERMT1 (also known as KIND1) gene
that encodes kindlin-1 (NP_060141;
Jobard et al., 2003; Siegel et al., 2003).
The proband was an 8-year-old boy
born to consanguineous parents. Soon
after birth, he developed blistering on
both hands and progressive poikilo-
derma on his neck. In 2005, a previously
undetectable brown macule was seen
on his right hand (Figure 1a). In 2008, a
small patch of normal-looking skin was
identified at the same site (Figure 1b)
but did not significantly enlarge with
the growing size of the child’s hand
(Figure 1c). No other normal-looking
patches of skin were present. Following
informed written consent and in com-
pliance with the Declaration of Helsinki
Principles, a peripheral blood sample
and skin biopsies were taken from the
proband. Immunofluorescence micro-
scopy labeling, illustrated in Figure 1d
and Supplementary Figures S1a–f online
and performed as previously described
(Lai-Cheong et al., 2008), showed
similar labeling patterns and intensity
in both normal and revertant skin along
the basal epidermal layer and basement
membrane zone for kindlin-1, hemi-
desmosomal-associated proteins (a6
and b4 integrin subunits), basement
membrane components (type VII col-
lagen and laminin-332), and epidermal
stem cell markers (b1 integrin and
keratin 15). It is noteworthy that the
pattern of kindlin-1 immunostaining in
the revertant skin was continuous rather
than patchy, and appeared similar to
the normal skin control.
Bidirectional sequence analysis of
genomic DNA extracted from a periph-
eral blood sample, as well as from
revertant and non-revertant KS skin and
keratinocytes (for details, see Supple-
mentary file online) from the proband,
showed a homozygous insertion of a
cytosine in exon 5 of the FERMT1 gene
(Figure 1e). Both parents were found to
be heterozygous for the same FERMT1
mutation. The mutation, denoted
c.676dupC (p.Gln226fsX17), is pre-
dicted to result in a premature termina-
tion codon (TGA) 35 bases downstream
and was excluded in 200 control
chromosomes. This result ruled out
back mutation as a reversion mechan-
ism. Furthermore, a second-site muta-
tion was not identified either upstream
or downstream of the frameshift. Gene
conversion and intragenic crossover
could be excluded as reversion me-
chanisms, as the affected subject was
homozygous for the mutation. At the
complementary DNA (cDNA) level, the
mutation was identified in non-reverted
KS skin and keratinocytes, but surpris-
ingly was no longer present in the
reverted skin and keratinocytes (Figure
1f). To exclude PCR errors, the experi-
ment was repeated using high-fidelity
DNA polymerase (Platinum Pfx DNA
polymerase; Invitrogen, Eugene, OR).
Contamination by normal control
cDNA was ruled out by the finding of
identical single-nucleotide polymorph-
ism pattern in both reverted and non-
reverted KS skin and keratinocytes
compared with normal control (data
not shown). Furthermore, real-time PCR
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Figure 2. Assessment of cell morphology and integrin activation status. (a) In normal human keratinocytes, active b1-integrin subunit (red) localized at
focal adhesions (white arrows). (b) In non-revertant keratinocytes, there was a marked reduction in active b1-integrin subunit at focal adhesions at the cell
periphery (yellow arrows). Furthermore, these cells had a predominantly elongated morphology. (c) In the revertant keratinocytes, there was bright-intensity
labeling for active b1-integrin subunit at focal adhesions (white arrow); bar¼20 mm.
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performed in triplicate showed that
the relative levels of FERMT1 mRNA
expression in the revertant skin were
similar to that in the control skin,
whereas in non-revertant skin the
FERMT1 mRNA expression was B9%
(Supplementary Figure S1g online).
Real-time PCR comparison of FERMT1
mRNA expression between revertant
and non-revertant keratinocytes
showed a finding similar to whole skin
analysis. Real-time PCR quantification
of FERMT1 mRNA expression in fibro-
blasts from revertant, non-revertant,
and normal skin showed undetectable
levels of FERMT1 mRNA (data not
shown).
We then determined whether the
presence of kindlin-1 in the revertant
keratinocytes was functionally signifi-
cant. As kindlin-1 is important for
b1-integrin activation, we assessed
the status of b1-integrin activation in
the revertant keratinocytes. Confocal
microscopy showed bright-intensity
active b1-integrin labeling (mouse
mAb; clone 12G10, gift from Professor
Martin Humphries, University of
Manchester, UK) at focal adhesions in
the revertant keratinocytes, in contrast
to the markedly reduced labeling in
the non-revertant KS keratinocytes
(Figure 2). Furthermore, phase-contrast
images showed that the revertant kera-
tinocytes displayed predominantly
round morphology with subtle filopo-
dial protrusions. The non-revertant KS
keratinocytes contrastingly had elon-
gated shapes and prominent filipodial
protrusions (Figure 2).
An important finding was the pre-
sence of a high level of FERMT1 mRNA
expression in both reverted skin and
keratinocytes. Our data showed that
the in vivo reversion resulted from the
loss of the extra cytosine in the mRNA
(c.676dupC to wild type), despite
the genomic DNA still containing the
mutation. Potential mechanisms that
could have induced correction are
transcriptional slippage and RNA edit-
ing. Transcriptional slippage has been
reported in genes containing homo-
polymeric tracts and results from an
enzymatic error, leading to the produc-
tion of a heterogeneous pool of mRNAs
with different numbers of nucleotides
and reading frames (Tamas et al.,
2008). However, the argument against
transcriptional slippage in our case is
that our sequence data are extremely
clean, suggestive of a homogeneous
mRNA population. RNA editing, on
the other hand, is a posttranscriptional
process that changes the nucleotide
sequence of an mRNA transcript from
the DNA sequence (Nishikura, 2006).
RNA editing that involves deletion
of a base pair has, to date, not been
reported in mammals. In the skin,
transcriptional modification leading to
partial RM was previously suggested
in a case of recessive epidermolysis
bullosa simplex (Schuilenga-Hut et al.,
2002). The authors postulated that a
second somatic modulating factor
could have affected pre-mRNA splic-
ing of mutant KRT14, but the under-
lying mechanism was not clarified
(Schuilenga-Hut et al., 2002).
In conclusion, we have reported an
original finding of RM in an individual
with KS resulting from a spontaneous
correction of a FERMT1 mutation. Our
data underscore the key roles of kin-
dlin-1 in skin homeostasis, as in vivo
recovery of kindlin-1 in the skin results
in clinically and structurally healthy
skin, and at a cellular level restoration
of integrin activation.
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